Skin and Lung Tuberculosis and Anti Tuberculosis Drug Liver Injury (ATLI)
Journal: International Journal of Science and Research (IJSR) (Vol.6, No. 8)Publication Date: 2017-08-05
Authors : I Ketut Kwartantaya Winaya; I Made Suma Wirawan;
Page : 2260-2264
Keywords : antituberculosis; liver injury; ATLI; extrapulmonary tuberculosis;
Abstract
Female, 57 years old with cutaneus and lung tuberculosis lesion, came to hospital with chief of complaint nausea, and vomiting after taking an oral antituberculosis for one month. Patient with lung tuberculosis and extrapulmonary (cutaneus tuberculosis) but unknown liver cirrhotic before oral antituberculosis treatment. Laboratory results revealed increased AST, ALT, total bilirubin and decreased liver function. Patient diagnosed with cutaneus and lung tuberculosis with anti Tuberculosis drug Liver Injury (ATLI). Drugs cessation and monitoring of clinical symptoms and liver function profiles is recommended before treatment. Re-introduction and continuing ATT could be done with tight monitoring.
Other Latest Articles
- Sedimentation at the Rokan River Estuary Bagansiapiapi Riau Province Indonesia
- A Literature Review on Parameters based MANET Routing Protocols
- Study of Energy Analysis for the Using of Heating and Rubbing Method for Recycling of Demolished Concrete
- A Study to Assess the Knowledge and Attitude Regarding Importance of Colostrum among Postnatal Mothers in Selected Hospitals
- Gastrointestinal Stromal Tumors: Case Series of a Single Institution Experience
Last modified: 2021-06-30 19:52:24